BLACK WEEKSFlacons −15% · kits −10% · reste −5%avec le codeLivraison gratuite en Allemagne dès 200 €

Cette page a été traduite automatiquement et peut contenir des erreurs. Vous êtes de langue maternelle française ? Vos remarques et corrections sont les bienvenues.Envoyer un retour

The Peptide Desk The Peptide Desk
Telmisartan, photo du produit

Rapport de laboratoire

PDF
Testé
Testé
Telmisartan 40mg × 100 Tabs
Laboratoire
Analiza Białek
Date
October 2026
Résultat
39.80 mg per tablet (40 mg label)
N° de commande
Mot de passe

Testé de manière indépendante, vérifiable avec le mot de passe directement auprès du laboratoire.

Medication

Telmisartan

Medication

Commande

Prix unitaire - Livraison gratuite en Allemagne dès 200 € pendant les Black Weeks
  • DHL avec suivi
  • Emballage discret

4.6 sur 5 sur Trustpilot73 avis

En un coup d'œil

Telmisartan en chiffres

Les chiffres clés de notre lexique. Faites glisser le point le long de la courbe pour voir ce qui reste après une dose, par calcul.

Article complet du lexique

How long does it stay in the body?

Share left after one dose, calculated with a half-life of ~24 hours

Half-life ~24 hours
After 48 hours: 25 %
Hour 2450 %Hour 4825 %Hour 7212.5 %Hour 1203.1 %

Simplified model without an absorption phase, half-life from the TPD lexicon.

Half-life

Approximately24hours

Class
Angiotensin II receptor antagonistARB
Use
Blood pressure controlcardiovascular protection
Sizes
40 to 80 mg2 sizes in the shop

Connaissances

Tout sur Telmisartan

Informations détaillées bientôt disponibles.

Dosage

Chargement des informations de dosage …

Plus d'infos dans le lexique

FAQ

Questions fréquentes

Sources pour chaque réponse : article du lexique

Encore une question ?

Écrivez-nous, notre équipe vous aidera.

Is telmisartan approved?

Yes. ChEMBL lists telmisartan with phase 4 as the highest phase and first approval in 1998. ClinicalTrials.gov lists 349 trials with telmisartan, as of 26 October 2026.

What did ONTARGET show?

25,620 patients with vascular disease or high-risk diabetes received ramipril, telmisartan or both. After about 56 months the primary outcome was 16.5, 16.7 and 16.3 percent. Telmisartan was equivalent, the combination brought no benefit but more side effects.

And if an ACE inhibitor is not tolerated?

TRANSCEND tested this in 5,926 patients against placebo. The primary outcome was not significantly less common at 15.7 versus 17.0 percent. Cardiovascular death, heart attack or stroke occurred in 13.0 versus 14.8 percent, also not significant after correction.

Why less cough than with ACE inhibitors?

According to ChEMBL telmisartan blocks the AT1 receptor and not the enzyme ACE. In ONTARGET 1.1 percent had cough with telmisartan, 4.2 percent with ramipril. Angioedema occurred in 0.1 versus 0.3 percent.

What was measured in heart failure with weak kidneys?

In a small open trial with 107 patients kidney function worsened less often than with enalapril after 3 months (6.4 versus 22.9 percent). Hospital stays for heart failure were less common (34.1 versus 55.3 percent), there were 5 deaths in each group.

What do the trials on insulin and combinations show?

In 70 patients with diabetes and high blood pressure HOMA-IR fell to 1.79 after 12 weeks instead of 3.45 with other blood pressure drugs. A meta-analysis of 3 trials found stronger blood pressure lowering with amlodipine and better LDL values with rosuvastatin, tolerability was similar.

Produits associés

Produits similaires